Navidea Biopharmaceuticals Inc

ASE:NAVB   3:59:53 PM EDT
-0.04 (-1.48%)
Earnings Announcements

Navidea Biopharmaceuticals Reports Q3 Loss Per Share Of $0.13

Published: 11/12/2020 21:17 GMT
Navidea Biopharmaceuticals Inc (NAVB) - Navidea Biopharmaceuticals Reports Third Quarter and Year-to-date 2020 Financial Results.
Q3 Revenue $268,000 Versus $237,000.
Q3 Loss per Share $0.13.